Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
NCT00029679 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2006-08-18
Summary
This study will assess clinical efficacy and/or adverse effects of dietary borage oil (which contains gamma-linolenic acid \[GLA\]) and Ginkgo biloba in patients with mild persistent to moderate asthma.
Conditions
Interventions
- DRUG
-
Gingko biloba
- DRUG
-
Borage oil
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 16 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Nutrition for Asthmatics
NCT06151405 ·Status: RECRUITING ·Phase: NA
-
Role of Herbs in the Management of Asthma
NCT02918487 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Prebiotics on Gut Bacterial Parameters, Immune Function & Exercise-Induced Airway Inflammation.
NCT02872675 ·Status: COMPLETED ·Phase: NA
-
Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
NCT01617746 ·Status: UNKNOWN ·Phase: PHASE2
-
Poor Response to Monoclonal Therapy in Asthma
NCT04114396 ·Status: UNKNOWN
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
NCT01329939 ·Status: COMPLETED ·Phase: NA
-
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
NCT01603277 ·Status: COMPLETED ·Phase: PHASE2
-
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
NCT00127166 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of Soy Isoflavones in Asthma
NCT01052116 ·Status: COMPLETED ·Phase: PHASE4
-
GB001 in Adult Subjects With Moderate to Severe Asthma
NCT03683576 ·Status: COMPLETED ·Phase: PHASE2
-
Fatty Acids in Airway Smooth Muscle of Asthmatics
NCT02809235 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children
NCT01087710 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
NCT05292976 ·Status: WITHDRAWN ·Phase: PHASE3
-
Controller Medications in the Management of Bronchial Asthma
NCT01055041 ·Status: COMPLETED ·Phase: NA
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Plant Stanol Esters and Preventing Asthma Symptoms
NCT03983603 ·Status: RECRUITING ·Phase: NA
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin for Uncontrolled Asthma
NCT02906761 ·Status: COMPLETED ·Phase: PHASE3
-
Center for Reducing Asthma Disparities - Harvard University/Boston Area Community Health Centers
NCT00281086 ·Status: COMPLETED
-
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.
NCT05352126 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
NCT00140946 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
NCT00766090 ·Status: COMPLETED ·Phase: PHASE2